Syneos Health, Inc. provides outsourced clinical development and commercialization services to biopharmaceutical companies. The company is headquartered in Morrisville, North Carolina and currently employs 24,000 full-time employees. The firm focuses on Phase I to Phase IV clinical development services for the biopharmaceutical and medical device industries. The firm operates through two segments: Clinical Development Services and Phase I Services. The firm’s Clinical Development Services segment offers a range of clinical development services, including full-service global studies, as well as ancillary services, such as clinical monitoring, investigator recruitment, patient recruitment, data management, study reports to assist customers with their drug development process, quality assurance audits and specialized consulting services. The Phase I Services segment focuses on clinical development services for Phase I trials, which include scientific exploratory medicine, first-in-human studies through proof-of-concept stages and support for Phase I studies in established compounds.